Research Report Screener Results

Chart, Financials, Historical Prices, Industry, Insider, Messages, Options, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-Nov-2009
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 75)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
30-Nov-09 Freedonia Group Inc, The The Freedonia Group Freedonia Focus on Medical & Dental Adhesives & Sealants 22 $500 View Abstract
30-Nov-09 Freedonia Group Inc, The The Freedonia Group Freedonia Focus on Cancer Therapies 23 $500 View Abstract
24-Nov-09 New Constructs, LLC N/A JNJ: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
23-Nov-09 Reuters Investment Profile N/A Johnson & Johnson: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Health Care Technologies Overview 2010 (Summary) 80 $199 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Nanotechnology & MEMS Industry Trends, Statistics & Analysis 2009 (Summary) 34 $199 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Nanotechnology & MEMS Industry Market Research and Competitive Analysis 2009 447 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Engineering & Research Industry Market Research and Competitive Analysis 2009 729 $299 View Abstract
Next 20

Brokerage Reports (Showing 1 to 10 of 13)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
13-Nov-09 Thomson StreetEvents N/A JNJ - Event Transcript of Johnson & Johnson conference call, Nov. 12, 2009 / 10:00am ET 9 $75 View Abstract
5-Nov-09 First Global Kavita Thomas, Devina Mehra First Global reiterates MarketPerform on GlaxoSmithKline Plc. 12 $25 View Abstract
3-Nov-09 Thomson StreetEvents N/A JNJ - Event Transcript of Johnson & Johnson conference call, Nov. 03, 2009 / 9:00am ET 22 $75 View Abstract
2-Nov-09 Capstone Investments N/A IMA: An Evolving Force in Personalized Medicine-Initiating with BUY & $47 Target 27 $75 View Abstract
24-Oct-09 First Global Kavita Thomas, Devina Mehra First Global reiterates ST MarketPerform on Eli Lilly & Co. 13 $50 View Abstract
23-Oct-09 First Global Kavita Thomas, Devina Mehra First Global reiterates MarketPerform on Merck & Co. (MRK) 12 $25 View Abstract
22-Oct-09 First Global Kavita Thomas, Devina Mehra First Global reiterates Moderate Outperform on Pfizer Inc 12 $25 View Abstract
15-Oct-09 First Global Kavita Thomas, Devina Mehra First Global reiterates ST MarketPerform on Abbott Inc. 13 $50 View Abstract
14-Oct-09 First Global Kavita Thomas, Devina Mehra First Global reiterates Moderate Outperform on Johnson & Johnson Inc. 15 $50 View Abstract
13-Oct-09 Hilliard Lyons Stephen A. O'Neil 3Q revenue declined but lower costs helped EPS exceed expectations 8 $25 View Abstract
Next 3

Independent Reports (Showing 1 to 10 of 62)

Release
Date Contributor Author Title Pages Price More Info
30-Nov-09 Freedonia Group Inc, The The Freedonia Group Freedonia Focus on Medical & Dental Adhesives & Sealants 22 $500 View Abstract
30-Nov-09 Freedonia Group Inc, The The Freedonia Group Freedonia Focus on Cancer Therapies 23 $500 View Abstract
24-Nov-09 New Constructs, LLC N/A JNJ: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
23-Nov-09 Reuters Investment Profile N/A Johnson & Johnson: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Health Care Technologies Overview 2010 (Summary) 80 $199 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Nanotechnology & MEMS Industry Trends, Statistics & Analysis 2009 (Summary) 34 $199 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Nanotechnology & MEMS Industry Market Research and Competitive Analysis 2009 447 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Engineering & Research Industry Market Research and Competitive Analysis 2009 729 $299 View Abstract
Next 20

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.